Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $773.9M
Liabilities Breakdown FY2018
Total Liabilities: $70.7M
Asset Breakdown
Total Assets: $773.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $92.4M | 11.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.6M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $754.0K | 0.1% |
| Other Assets | $672.1M | 86.8% |
Liabilities Breakdown
Total Liabilities: $70.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.3M | 17.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $58.4M | 82.5% |